Concord Drugs Ltd

Concord Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Concord Drugs Ltd

₹ 38.2 -0.39%
26 Jul - close price
concorddrugs.in BSE: 538965
About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Product Portfolio:[1]
a) Pharmaceutical Ready to fill Pellets
b) Multiple Unit Pellet System (MUPS)
c) Tissue Bio Adhesive
d) Injectables (Small Volume Parenterals)
e) Oral Solid Dosages (Tablets & Capsules)
f) Liquid Orals (Syrups & Suspensions)
g) Dry Syrup (Powder)

Website BSE
  • Market Cap ₹ 38.2 Cr.
  • Current Price ₹ 38.2
  • High / Low ₹ 61.5 / 30.1
  • Stock P/E 81.4
  • Book Value ₹ 33.8
  • Dividend Yield 0.00 %
  • ROCE 5.05 %
  • ROE 1.45 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 1.13 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has high debtors of 161 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
15.48 12.54 13.72 13.53 12.31 8.98 7.53 12.78 15.64
14.80 11.56 12.53 12.08 11.34 7.52 5.91 12.15 15.29
Operating Profit 0.68 0.98 1.19 1.45 0.97 1.46 1.62 0.63 0.35
OPM % 4.39% 7.81% 8.67% 10.72% 7.88% 16.26% 21.51% 4.93% 2.24%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.23 0.34 0.42 0.45 0.50 0.44 0.43 0.50 0.50
Depreciation 0.37 0.39 0.53 0.38 0.33 0.38 0.39 0.39 0.39
Profit before tax 0.08 0.25 0.24 0.62 0.14 0.64 0.80 -0.26 -0.54
Tax % 62.50% 28.00% 25.00% 25.81% -21.43% 23.44% 30.00% -3.85% -38.89%
0.03 0.19 0.18 0.45 0.16 0.49 0.56 -0.24 -0.34
EPS in Rs 0.03 0.22 0.21 0.51 0.17 0.53 0.60 -0.24 -0.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
58.96 52.08 44.93
53.37 47.51 40.88
Operating Profit 5.59 4.57 4.05
OPM % 9.48% 8.77% 9.01%
0.10 0.01 0.00
Interest 1.68 1.71 1.87
Depreciation 1.76 1.63 1.56
Profit before tax 2.25 1.24 0.62
Tax % 28.89% 20.97% 25.81%
1.59 0.99 0.47
EPS in Rs 1.82 1.06 0.47
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -53%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 11%
1 Year: 31%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Equity Capital 8.74 9.32 10.00
Reserves 19.62 21.82 23.82
16.43 16.96 16.60
11.66 10.13 8.39
Total Liabilities 56.45 58.23 58.81
13.97 12.92 11.68
CWIP 0.55 0.92 1.63
Investments 0.00 0.89 0.84
41.93 43.50 44.66
Total Assets 56.45 58.23 58.81

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
0.77 1.66 0.79
-2.44 -2.27 -1.01
1.68 0.62 0.28
Net Cash Flow 0.01 0.02 0.07

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 141.52 110.80 161.09
Inventory Days 151.64 178.58 251.53
Days Payable 62.25 46.92 37.75
Cash Conversion Cycle 230.90 242.47 374.87
Working Capital Days 198.84 252.16 317.23
ROCE % 6.35% 5.05%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
49.00% 49.00% 49.00% 49.00% 49.00% 49.00% 52.13% 52.13% 52.13% 55.41% 55.41% 55.41%
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 47.87% 47.87% 47.87% 44.59% 44.60% 44.60%
No. of Shareholders 2,8263,0713,0473,0363,1883,3213,2043,1983,9574,0324,7344,755

Documents

Announcements

Annual reports

Credit ratings